...
首页> 外文期刊>The Journal of biological chemistry >IRAK1 and IRAK4 Promote Phosphorylation, Ubiquitination, and Degradation of MyD88 Adaptor-like (Mal)
【24h】

IRAK1 and IRAK4 Promote Phosphorylation, Ubiquitination, and Degradation of MyD88 Adaptor-like (Mal)

机译:伊拉克1和伊拉克4促进磷酸化,泛素化和降解MyD88适配器(MAL)

获取原文

摘要

Signal transduction by Toll-like receptor 2 (TLR2) and TLR4 requires the adaptors MyD88 and Mal (MyD88 adaptor-like) and serine/threonine kinases, interleukin-1 receptor-associated kinases IRAK1 and IRAK4. We have found that both IRAK1 and IRAK4 can directly phosphorylate Mal. In addition, co-expression of Mal with either IRAK resulted in depletion of Mal from cell lysates. This is likely to be due to Mal phosphorylation by the IRAKs because kinase-inactive forms of either IRAK had no effect. Furthermore, lipopolysaccharide stimulation resulted in ubiquitination and degradation of Mal, which was inhibited using an IRAK1/4 inhibitor or by knocking down expression of IRAK1 and IRAK4. MyD88 is not a substrate for either IRAK and did not undergo degradation. We therefore conclude that Mal is a substrate for IRAK1 and IRAK4 with phosphorylation promoting ubiquitination and degradation of Mal. This process may serve to negatively regulate signaling by TLR2 and TLR4.
机译:通过Toll样受体2(TLR2)和TLR4的信号转导需要适配器MYD88和MAL(MYD88α样)和丝氨酸/苏氨酸激酶,白细胞介素-1受体相关的激酶IRAK1和IRAK4。我们发现伊拉克1和伊拉克人都可以直接磷酸化。此外,具有伊拉克的MAL的共同表达导致来自细胞裂解物的MAL耗尽。这可能是由于伊拉克的磷酸化,因为伊拉克的激酶 - 非活性形式无效。此外,脂多糖刺激导致MAL的泛素化和降解,其使用IRAK1 / 4抑制剂或通过敲下伊拉克1和IRAK4的表达来抑制。 MyD88不是伊拉克的底物,并且没有经历降解。因此,我们得出结论,MAL是伊拉克1和伊拉克4的底物,促进脱脂和恶性降解的磷酸化。该过程可以用于通过TLR2和TLR4对信号负化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号